Ibotta, Inc. operates a Denver-based performance marketing platform that links consumer packaged goods brands with shoppers through its Ibotta Performance Network. The company, founded in 2012, lets users earn cash-back on purchases ranging from groceries to travel via its app and browser tools. Brands pay only for results through integrations with major retailers and platforms. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Partnerships with names like Walmart and Uber Eats give it a unique spot in ad-tech and retail media, and metrics around redemptions and publisher growth provide investors with timely signals on CPG spending trends.
From a July 6, 2026 close of $33.00 to $37.34 on August 4, 2026, IBTA advanced roughly 13.2%. The move included sharp swings, with a steady decline through late July that bottomed at $24.00 before a 51.9% single-day jump on the earnings release. Over the full three-month period the stock stayed nearly flat at around +0.9%, starting near $37 in early May, dropping sharply mid-quarter, and recovering to end close to where it began. This pattern shows how much the near-term direction depends on quarterly results and guidance updates.
The main driver was the Q2 2026 earnings report released August 3. Revenue reached $88.91 million, up 3.3% year over year and the first growth quarter since Q1 2025, beating estimates by about 4.7%. Adjusted EBITDA of $16.5 million exceeded the $10.5 million guidance midpoint and consensus by a wide margin. Adjusted EPS of $0.46 also topped the $0.37 estimate. Third-party publisher revenue rose 27% to $61.5 million while total redeemers increased 21% to 20.9 million. Q3 guidance of $86–$90 million came in above the $85.7 million consensus. I reviewed the earnings details alongside Tickeron’s AI Trend Prediction Engine to gauge momentum signals. Analyst responses followed quickly: Wells Fargo raised its target to $40, Evercore ISI to $42, and Needham kept a Buy rating at $45. Goldman Sachs lifted its target to $32 while keeping a Sell rating. The stock surged 51.9% that day. Offsetting factors included insider sales of roughly 613,000 shares worth $18.7 million in the prior 90 days and a 24% drop in direct-to-consumer redemption revenue.
Over three months the stock reflected tension between improving fundamentals and ongoing doubts. Shares started near $37 in May, then fell through June and July amid concerns over flat top-line results, negative margins, and questions about publisher growth sustainability. A large insider sale in early July added to the pressure. Revenue per redemption slipped 4% to $0.88 even as user numbers rose. The Q2 report shifted the story by showing 27% growth in third-party publisher revenue and renewed year-over-year growth in most enterprise accounts. The quarter traced a sharp V-shape, highlighting how binary market reactions have become around earnings and the durability of the turnaround.
Several developments will likely influence the stock next. The 7-Eleven rollout across more than 11,500 U.S. locations in the second half of 2026 could lift redemption volumes and publisher revenue. A next-generation product suite planned for 2027 offers another potential catalyst. Investors will want to track whether mid-single-digit revenue growth holds and whether adjusted EBITDA margins stabilize after the expected Q3 compression toward 15%. Broader economic sensitivity in CPG ad budgets remains a risk, as does the ongoing decline in direct-to-consumer and ad revenue streams. With the consensus rating still at "Reduce" and price targets spanning $22 to $45, upcoming quarters will test whether the August move marks a lasting shift or a one-off reaction.
When analyzing names like IBTA, I often review Tickeron’s Trending AI Robots for algorithmic ideas. The page highlights top-performing bots across strategies with transparent metrics, win rates, and trade details, making it straightforward to match approaches to specific trading goals.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.
IBTA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 14 of 16 cases where IBTA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 88%.
The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on IBTA as a result. In 31 of 44 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.
Following a +5.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBTA advanced for three days, in 108 of 143 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The Aroon Indicator entered an Uptrend today. In 81 of 113 cases where IBTA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 72%.
The 10-day RSI Indicator for IBTA moved out of overbought territory on September 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator moved out of overbought territory. In 14 of the 16 cases, the stock moved lower in the following days. This puts the odds of a move lower at 88%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Moving Average Convergence Divergence Histogram (MACD) for IBTA turned negative on September 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 18 similar instances when the indicator turned negative. In 13 of the 18 cases the stock turned lower in the days that followed. This puts the odds of success at 72%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. IBTA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.342) is normal, around the industry mean (51.922). P/E Ratio (307.083) is within average values for comparable stocks, (82.636). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.135). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (3.156) is also within normal values, averaging (70.495).
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IBTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PackagedSoftware